← Leaderboards
David Roy Bangsberg
University Of California San Francisco
$24,881,545
Attributed
$24,881,545
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3M · FY2005–14$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$24,881,545 · 9
By mechanism
R01$21,926,286 · 3
K24$1,455,968 · 2
R21$1,348,208 · 2
R03$151,083 · 1
M01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Cheryl Zlotnick$188,772
- Maria L Ekstrand$16,093,949
- Joseph R Guydish$12,569,899
Others in their field
Top investigators on “Drug Resistance”
- Judith S. Currier · University Of California Los Angeles$207,752,958
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$145,910,108
- Ralph Parchment · Leidos Biomedical Research, Inc.$140,676,376
- Daniel R Kuritzkes · Brigham And Women'S Hospital$114,882,802
- Peter C Adamson · National Childhood Cancer Foundation$114,476,581
- Wafaa M. El-Sadr · Columbia University Health Sciences$113,453,088
Research focus
Drug ResistancePatient Oriented ResearchHiv InfectionsHuman SubjectAfricanAntiretroviral TherapyAfrica South Of The SaharaResearch PersonnelProgramsUgandaResourcesResistanceAdherence (Attribute)ViralTreatment OutcomeAnti-Retroviral AgentsAfricaBehavioral /Social Science Research TagPharmaceutical PreparationsTherapy ComplianceClinical ResearchAids TherapyFundingPublications
Grant awards (47)
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa$1,122,416
R01 · FY2014 · MH · contact PI
Epidemiology of atherosclerosis among older-age individuals with HIV in Uganda$180,498
R21 · FY2014 · HL · contact PI
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa$1,091,958
R01 · FY2013 · MH · contact PI
Mentoring Patient Oriented Adherence Research in Uganda$155,220
K24 · FY2013 · MH · contact PI
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa$1,162,415
R01 · FY2012 · MH · contact PI
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa$298,844
R01 · FY2012 · MH · contact PI
Mentoring Patient Oriented Adherence Research in Uganda$155,220
K24 · FY2012 · MH · contact PI
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa$701,794
R01 · FY2011 · MH · contact PI
Mentoring Patient Oriented Adherence Research in Uganda$155,220
K24 · FY2011 · MH · contact PI
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa$1,244,641
R01 · FY2010 · MH · contact PI
Mentoring Patient Oriented Adherence Research in Uganda$155,134
K24 · FY2010 · MH · contact PI
International HIV ARV Adherence, Resistance and Survival$1,266,563
R01 · FY2009 · MH · contact PI
Mentoring Patient Oriented Adherence Research in Uganda$155,164
K24 · FY2009 · MH · contact PI
International HIV ARV Adherence, Resistance and Survival$1,066,318
R01 · FY2008 · MH · contact PI
International HIV ARV Adherence, Resistance and Survival$423,201
R01 · FY2008 · MH · contact PI
HIV Outcomes Research and Training in Uganda$136,873
K24 · FY2008 · AA · contact PI
International HIV ARV Adherence, Resistance and Survival$1,929,927
R01 · FY2007 · MH · contact PI
HIV Outcomes Research and Training in Uganda$104,036
K24 · FY2007 · AA · contact PI
HIV Outcomes Research and Training in Uganda$32,837
K24 · FY2007 · AA · contact PI
International HIV ARV Adherence, Resistance and Survival$1,533,566
R01 · FY2006 · MH · contact PI
A RCT of HIV Adherence Case Management and Modified DOT$687,149
R01 · FY2006 · MH · contact PI
HIV Outcomes Research and Training in Uganda$136,873
K24 · FY2006 · AA · contact PI
International HIV ARV Adherence, Resistance and Survival$1,716,242
R01 · FY2005 · MH
A RCT of HIV Adherence Case Management and Modified DOT$783,429
R01 · FY2005 · MH
Alcohol use and ARV treatment outcomes in Uganda$372,570
R21 · FY2005 · AA
HIV Outcomes Research and Training in Uganda$135,728
K24 · FY2005 · AA
HIV Treatment in the homeless: a prospective study$1,443,598
R01 · FY2004 · MH
A RCT of HIV Adherence Case Management and Modified DOT$751,152
R01 · FY2004 · MH
Depression Treatment to Improve ARV Therapy Adherence$607,885
R01 · FY2004 · MH
Alcohol use and ARV treatment outcomes in Uganda$372,570
R21 · FY2004 · AA
HIV Outcomes Research and Training in Uganda$133,663
K24 · FY2004 · AA
Alcohol use and ARV treatment outcomes in Uganda$50,000
R21 · FY2004 · AA
HIV Treatment in the homeless: a prospective study$1,423,808
R01 · FY2003 · MH
A RCT of HIV Adherence Case Management and Modified DOT$659,471
R01 · FY2003 · MH
Depression Treatment to Improve ARV Therapy Adherence$583,487
R01 · FY2003 · MH
Alcohol use and ARV treatment outcomes in Uganda$372,570
R21 · FY2003 · AA
A RCT of HIV Adherence Case Management and Modified DOT$116,941
R01 · FY2003 · MH
Antiretviral therapy adherence in resource poor setting$75,750
R03 · FY2003 · MH
Depression Treatment to Improve ARV Therapy Adherence$706,858
R01 · FY2002 · MH
Antiretviral therapy adherence in resource poor setting$75,333
R03 · FY2002 · MH
TRIAL OF MULTI-INFECTION COUNSELING AND TESTING$0
M01 · FY2002 · RR
TRIAL OF MULTI-INFECTION COUNSELING AND TESTING$0
M01 · FY2002 · RR
Depression Treatment to Improve ARV Therapy Adherence$604,623
R01 · FY2001 · MH
TRIAL OF MULTI-INFECTION COUNSELING AND TESTING$0
M01 · FY2001 · RR
TRIAL OF MULTI-INFECTION COUNSELING AND TESTING$0
M01 · FY2000 · RR
TRIAL OF MULTI-INFECTION COUNSELING AND TESTING$0
M01 · FY2000 · RR
TRIAL OF MULTI-INFECTION COUNSELING AND TESTING$0
M01 · FY2000 · RR